Streetbeat News

Stock Prices

GROM

Grom Social Enterprises Inc. (NASDAQ:GROM) shares are trading higher despite no company-specific news. The stock is trending on Yahoo! Finance and has attracted attention from short-sellers and retail investors. The shares are up 25% at $2.19. The company is a media, technology, and entertainment firm delivering content to children under 13 through a secure platform.

Portfolio Pulse from Erica Kollmann

October 05, 2023 | 2:32 pm

LEVI

Levi Strauss & Co. (NYSE:LEVI) is set to release its Q3 financial results on Oct. 5, 2023. Analysts predict a decrease in earnings per share and revenue compared to the same period last year. The company's shares gained 1.7% to close at $13.43 on Wednesday. Several analysts have maintained their ratings but cut their price targets for the company.

Portfolio Pulse from Lisa Levin

October 05, 2023 | 2:31 pm

ADP

Automatic Data Processing (NASDAQ:ADP) has outperformed the market over the past 15 years by 3.11% on an annualized basis, producing an average annual return of 14.1%. If an investor had bought $100 of ADP stock 15 years ago, it would be worth $696.78 today.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 2:30 pm

GPN

Global Payments (NYSE:GPN) has outperformed the market over the past 15 years, producing an average annual return of 12.02%. If an investor had bought $100 of GPN stock 15 years ago, it would be worth $565.71 today.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 2:30 pm

LVOX

Northland Capital Markets analyst Michael Latimore has downgraded LiveVox Holdings (NASDAQ:LVOX) from Outperform to Market Perform.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:30 pm

SPY

UNG

USO

USA Natural Gas Storage reported a figure of 86B, lower than the estimated 92B and the prior figure of 90B.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:30 pm

NEE

NextEra Energy's stock has been downgraded from Overweight to Sector Weight by Keybanc, leading to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:30 pm

SABS

Ladenburg Thalmann analyst Jeffrey Cohen has downgraded SAB Biotherapeutics (NASDAQ:SABS) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 2:28 pm

OKYO

OKYO Pharma Limited's drug candidate, OK-101, currently in a phase 2 trial for dry eye disease (DED), is showing a positive safety profile. The trial involves 240 patients, with 95% having completed four weeks of dosing. The company expects the last patient's last visit to occur in November 2023, with top-line data to be released in December 2023. DED affects approximately 49 million people in the US. OKYO shares are down 17.60% at $2.29.

Portfolio Pulse from Vandana Singh

October 05, 2023 | 2:27 pm

SP

Parking company SP Plus Corporation (NASDAQ: SP) is set to be acquired by Metropolis Technologies, Inc. for $54.00 per share in cash, a 52% premium to SP's closing stock price on October 4, 2023. The enterprise value of the acquisition is approximately $1.5 billion. Metropolis has secured $1.7 billion in equity and debt financing for the transaction, which is expected to close in 2024.

Portfolio Pulse from Shivani Kumaresan

October 05, 2023 | 2:25 pm